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DObjective: We investigated whether use of radial artery versus saphenous vein grafts during coronary artery
bypass grafting reoperations is associated with a significant long-term survival benefit.
Methods: We reviewed a series of 347 consecutive coronary artery bypass grafting reoperations (1996–2007;
270 [78%] male patients; age, 65.3  9.2 years). Internal thoracic artery grafts were used in 248 (71%) patients
at the time of the first coronary artery bypass grafting operation and in 154 (44%) patients at reoperation. Patients
were grouped based on whether a functional radial artery graft was present after coronary artery bypass grafting
reoperation (radial artery cohort, n¼ 203 [59%]) or not (saphenous vein cohort, n¼ 144 [41%]). Median time to
reoperation was similar for the radial artery (10.3 years) and saphenous vein (10.1 years) cohorts (P ¼ .55).
Angiographic data were used to ascertain the number and type of grafts that remained functional from initial cor-
onary artery bypass grafting. Survival data (12 years) were time segmented based on multiphase hazard mod-
eling at 90 days, and late survival was then analyzed by using proportional hazard Cox regression, with risk
adjustment based on a radial artery–use propensity score computed from 48 covariates, including time to reop-
eration, month of surgical intervention, and total arterial and vein grafts after reoperation. Propensity-matched
and propensity quintile comparisons were also done.
Results: Follow-up was similar for the radial artery versus saphenous vein cohorts (5.7 3.4 vs 5.8 4.0 years,
P ¼ .86), and 112 (50 in the radial artery and 62 in the saphenous vein cohorts) deaths were documented. Early
mortality (90 days) did not differ for the radial artery (7.4%) and saphenous vein (12.5%) cohorts (P ¼ .14).
Unadjusted late outcomes were superior for the radial artery versus saphenous vein cohorts, with survival of
97.3% versus 92.9%, 84.9% versus 77.2%, and 74.1% versus 60.3% at 1, 5, and 10 years, respectively.
Propensity-adjusted radial artery survival was superior, with a hazard ratio of 0.58 (P ¼ .04), and this result
was confirmed in a propensity-matched comparison.
Conclusions: We conclude that the use of radial artery as opposed to saphenous vein grafting for reoperative
coronary artery bypass grafting, either with or without concomitant internal thoracic artery grafts, is associated
with a substantial improvement in late survival. This benefit is likely derived from the increased overall number
of arterial grafts. (J Thorac Cardiovasc Surg 2010;139:1511-8)Supplemental material is available online.vonne Viens, SGM, Research Institutea -Saint Vincent Mercy Medical Center,
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The Journal of Thoracic and CarEvidence of the benefits of arterial grafts on late outcomes of
coronary artery bypass grafting (CABG) has accumulated
over the past 2 decades.1-7 The left internal thoracic artery
(LITA)/left anterior descending artery (LAD) graft has be-
come the standard of care in patients undergoing primary
CABG when LAD disease is present.1,2 Several groups
have also reported that further improvement in late survival
is achieved by using additional arterial grafts, such as a sec-
ond internal thoracic artery (ITA)3,4 or radial artery (RA)
graft,5-8 as opposed to the conventional operation combining
LITA/LAD with saphenous vein (SV) grafting.
Currently, there is a paucity of data on what is the optimal
grafting method in case of reoperative CABG, particularly
related to late outcomes. This has been confounded, in recent
years, by the fact that many, if not a majority, of the patients
presenting for repeat CABG might have had at least 1 ITA
graft used during their first operation. The re-emergence of
the RA graft and its demonstrated survival benefit after pri-
mary CABG put forth the possibility of a similar late RAdiovascular Surgery c Volume 139, Number 6 1511
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Acquired Cardiovascular Disease Zacharias et al15Abbreviations and Acronyms12CABG ¼ cTheoronary artery bypass graftingITA ¼ internal thoracic artery
LAD ¼ left anterior descending artery
LITA ¼ left internal thoracic artery
RA ¼ radial artery
SV ¼ saphenous veinbenefit after CABG reoperation. In this study we analyzed
the CABG reoperation experience at our institution with
the primary aim of testing the hypothesis that use of RA
grafting for repeat CABG will confer a significant long-term
survival benefit when compared with SV grafting.
MATERIALS AND METHODS
This investigation is a retrospective analysis of a prospectively collected
cardiac surgery database approved by the institutional review board, and in-
formed consent was waived for this study. The database is collected and
reported in accordance with the Society of Thoracic Surgeons’ national
database criteria.
Study Population
Patients undergoing reoperative CABG between January 1, 1996, and
December 31, 2007, were considered for inclusion in this study. Patients
were excluded if they underwent concomitant valve surgery, aortic surgery,
or both during their operation or if they received ITA grafts exclusively
(n ¼ 8). The final study population consisted of 347 patients (270 [78%]
male patients; age, 65.3  9.2 years) divided into 2 subcohorts irrespective
of their ITA grafting during reoperation (Table 1): the RA cohort consisted
of 203 (59%) patients who either received 1 or more RA grafts at reopera-
tion (n¼ 200, with or without additional SV grafts) or had remaining patent
RA grafts from the first CABG (n¼ 3), and the SV cohort consisted of 144
(41%) patients with SV and no RA grafting at reoperation. Patients’
demographic, comorbidity, and operative data for the RA and SV cohorts
are summarized in Table 2. Annual volumes and their breakdown to the
RA and SV cohorts are provided in Table E1.
The overall cohort included 283 (82%) isolated CABGs, whereas 64
underwent CABG combined with other noncardiac (eg, lung or carotid
operations) or cardiac (eg, the maze procedure or ventricular aneurysm
repair) procedures. Cardiopulmonary bypass was used in a large majority
of patients, with only 23 (6.6%) of 347 study patients undergoing off-
pump surgery. Over the 1996–2007 study period, the annual volumes var-
ied between 9 and 48 cases per year (median, 32 cases). The initial
CABG operation occurred over a period of 3 decades (1973–2005).
The annual distribution of initial CABG and the corresponding increasing
rate of ITA use at the time of the first operation are shown in Figure 1
(top). Median time to reoperation was similar for the RA (10.3 years)
and SV (10.1 years) cohorts (Figure 1, bottom). A large majority of pa-
tients underwent their first reoperation CABG (n ¼ 333 [96%]) compared
with 12 who underwent their second (7 in the RA cohort and 5 in the
SV cohort) and 2 (both in the RA cohort) who underwent their third
reoperations.
Data Collection
Coronary catheterization reports before the index CABG reoperation
were retrieved, and the status of previously placed grafts, including type
of conduit and coronary targets, was recorded. For this study, a coronary
graft was considered to be an anastomotic failure in case of (1) completeJournal of Thoracic and Cardiovascular Surocclusion, (2) stenosis of 75% or greater, or (3) presence of extensive
conduit narrowing or ‘‘string sign.’’ Long-term all-cause mortality data
were secured from our service patient follow-up and verified from
individual patient queries of the United States Social Security Death Index
database (http://ssdi.genealogy.rootsweb.com) in September 2008. Data-
base records were updated for missing death information when necessary.
Allowing for a 3-month lag in the Social Security Death Index database,
this corresponds to a minimum of 6 (December 2007 patients) and
a maximum of 150 (January 1996 patients) months’ follow-up.
Coronary Grafts
A summary of the number and type of completed grafts during the initial
CABG operation of the RA and SV reoperative CABG cohorts is provided
in Table 1. This table also shows the respective failure rates of these original
grafts, as observed at the time of the index redo CABG operation. Expanded
data, including the target-conduit use and graft failure data from the initial
CABG operation, both combined and separated for the RA and SV cohorts,
are provided in Tables E2 to E7. Lastly, grafting data at the index CABG
reoperation are summarized for both cohorts in Table 2, whereas the related
target-conduit use data from the reoperation are provided in Table E8. Note
that for the 347 members of the total redo CABG population, 154 (44.3%)
had ITAs used at reoperation, and this was similar for the 2 study cohorts
(RA vs SV, 87/203 [43%] vs 67/144 [47%]; P> .2; Table 2). At least
1 functional (patent) ITA graft was present in 179 (88%) RA cohort and
118 (82%) SV cohort patients after the CABG reoperation. The 200 RA
cohort patients received 260 radial grafts (1.3 per patient) achieved by
means of bilateral radial use in 37 patients and construction of sequential
radial grafts in 21 patients.
Surgical Technique
The approach to reoperative CABG was similar to that seen in other
studies.9,10 The surgical technique of RA harvesting and its intraoperative
management in case of CABG reoperation was similar to that described
for patients undergoing primary CABG.5-8 Briefly, the presence of periph-
eral vascular disease was not a criterion for excluding patients from RA
use per se. Hand collateral circulation and palmar arch status were as-
sessed by using the modified Allen test and Doppler ultrasonography, re-
spectively. Intraoperative plethysmography and oximetry were performed
before establishing cardiopulmonary bypass. The RA was explored
through a small incision, and harvesting was abandoned in case of
small-vessel caliber, significant calcification, or both. Harvesting was
done at the same time as the LITA dissection, with the RA removed as
a pedicle without electrocautery (harmonic scalpel) and immersed in di-
luted papaverine. Hydrostatic and mechanical dilatation were not used to
avoid intimal injury.
Bilateral RA harvesting was done in 37 (18.5%) of the 200 patients
undergoing reoperative CABG with RA grafts. RA use as a single graft
was predominant, whereas sequential RA grafts anastomosed to 2 or 3 target
vessels were used in 21 (10.5%) patients. RA grafts were generally placed
to target vessels greater than 1 mm in diameter, with a proximal stenosis of
greater than 70% in a large majority of patients. The inflow into the sequen-
tial RA was in the overwhelming majority of cases from the aorta, unless
aortic atherosclerosis or graft length issues precluded an RA to aorta anas-
tomosis. The RA grafts coursed over the surface of the heart in gentle curves
without acute angulation or kinking. The side-to-side anastomoses were
constructed in 2 ways: (1) a diamond configuration in which the graft
axis lies perpendicular to the axis of the target vessel or (2) a parallel con-
figuration in which the graft and target axis are aligned. The target-vessel
arteriotomy length in the diamond configuration was a function of the
size of the RA and was tailored to prevent a seagull deformity. The distal
anastomosis was constructed in either an anatomic (heel proximally or toe
distally on the target vessel) or antianatomic (heel distally or toe proximally)
fashion to facilitate a smooth course over the surface of the heart. The graft-
ing strategy was predicated on maximizing the number of target vesselsgery c June 2010
TABLE 1. Summaryof ‘‘initialCABG’’ grafting data with corresponding
failure rates at the time of reoperation*
RA at redo
operation (n ¼ 200)
SV/no RA at redo
operation (n ¼ 147)y
Failed Failed
Conduits Grafts (n) No. % Grafts (n) No. %
All types 560 310 55 374 240 64
SV 385 268 70 253 195 77
Arterial 175 42 24 121 45 37
RA 13 5 38 21 17 81y
ITA (any) 162 37 23 100 28 28
LITA 150 31 21 92 23 25
RITA 10 5 50 7 5 71
Free ITA 2 1 50 1 0 0
CABG, Coronary artery bypass grafting; RA, radial artery; SV, saphenous vein; ITA,
internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic
artery. *Related target-conduit use and graft failure data from the initial CABG
operation, both combined and separated for the RA and SV cohorts, are provided in
Tables E2 to E7. Target-conduit use data at the time of CABG reoperation are
provided in Table E8. yThree of 147 ‘‘SV/no RA at redo operation’’ patients
had 4 patent RA grafts from previous CABG operations. Therefore these 3 patients
were included in the RA cohort for the purposes of outcomes analysis, including in
Table 2 and Figures 3–5.
TABLE 2. Comparison of demographic, risk factor, and operative
data for the RA versus SV redo CABG cohorts
Variable/category RA group SV group P value
No. of patients 203 144
Demographics
Male sex 82% 72% .035
Age (y) 65  9 66  10 .067
Body mass Index (kg/m2) 30.8  5.3 28.5  5.2 .000
Body surface area (m2) 2.08  0.22 1.99  0.22 .000
Preoperative data
Smoker 69% 69% >.2
Current 16% 17% >.2
Diabetes 44% 40% >.2
Insulin dependent 13% 17% >.2
High cholesterol 88% 76% .004
Renal failure 2.5% 5.6% .136
Hypertension 86% 85% >.2
Peripheral vascular disease 19% 33% .002
Cerebrovascular disease 30% 35% >.2
Cerebrovascular accident 13% 9% >.2
Previous myocardial infarction 69% 67% >.2
Congestive heart failure 12% 9% >.2
Arrhythmia (any) 13% 19% .093
Chronic lung disease 20% 26% >.2
NYHA classification (I-IV) 2.98  0.87 3.20  0.79 .027
Class III/IV 74% 84% .032
Coronary vessel disease (1, 2, 3) 2.78  0.50 2.73  0.57 >.2
Left main disease 29% 40% .032
Ejection fraction (%) 46  10 47  9 >.2
IABP 8% 13% .151
Previous PTCA 50% 41% .157
Stent 31% 24% .148
b-Blockers 68% 70% >.2
ACE inhibitor 50% 43% >.2
Aspirin 87% 79% .062
Operative data
Emergency 1.0% 5.6% .012
Multiple reoperations 4.4% 3.5% >.2
Cardiopulmonary bypass (min) 125  50 115  74 .159
Crossclamp time (min) 63  32 49  33 .000
Off-pump 4.9% 9.0% .131
Other cardiac procedure 13.3% 7.6% .097
Other noncardiac procedure 7.4% 10% >.2
Grafting data
ITA used 43% 47% >.2
Left ITA 19% 28% .061
Right ITA 24% 21% >.2
SVG used 75% 100% .000
RA used 99% 0% .000
No. of grafts 2.93  1.07 2.48  0.87 .000
Arterial 1.72  0.72 0.49  0.55 .000
SV 1.21  0.91 1.99  0.81 .000
RA, Radial artery; SV, saphenous vein; CABG, coronary artery bypass grafting; NYHA,
New York Heart Association; IABP, intra-aortic balloon pump; PTCA, percutaneous
transluminal coronary angioplasty; ACE, angiotensin-converting enzyme; ITA, inter-
nal thoracic artery; SVG, saphenous vein graft.
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anastomosis to the best target with the best runoff. Over the course of the
study period, based on emerging data documenting suboptimal results of
RA durability in the right coronary artery system, RA use evolved such
that RAs were placed almost exclusively in the left coronary artery
distribution.
Propensity Score Models
The RA and SV redo CABG cohorts exhibited significant differences in
their demographic, risk factor, and operative variables (Table 2). Such
differences confound outcome comparisons in observational treatment
groups.11 To minimize such confounding when comparing the effects of
grafting methods on long-term survival, we used propensity score
adjustment in which RA grafting was considered treatment.11,12 Briefly,
the probability that a patient received RA grafts (or the RA-use propensity
score) was defined by a propensity score derived from a nonparsimonious
logistic multivariate model applied to all patients. Forty-eight variables
(highly redundant variables were avoided) were entered into the nonparsi-
monious model, irrespective of their significance, which included the vari-
ables shown in Table 1. Two additional time-related variables were also
included in the propensity model: (1) month of redo CABG entered as
a continuous month-of-series variable (January 1996¼1 up to December
2007¼144) to account for potential varying frequency of RA grafting
over the study time period and (2) first-to-redo surgical interval as a contin-
uous variable in years. Finally, the propensity model also included 3 vari-
ables defining the number of arterial (mostly ITA) and SV grafts from the
initial CABG operation that were functional (patent or<75% stenosis) at
the time of reoperation. Including these variables in the model ensured
that the survival comparisons are appropriately adjusted for the total number
of grafts (and hence completeness of revascularization), and it accurately
accounted for the total number of arterial versus venous grafts in the
comparison groups. Expectedly, the resulting propensity scores
were different (mean  standard deviation: 0.677  0.203 [RA cohort]
vs 0.455 0.207 [SV cohort]; P¼ .0000]. The C-statistic value for the pro-
pensity model was 0.79  0.02, indicating excellent discrimination. This
score was used in 3 complementary analyses: (1) risk-adjustment late
survival comparisons based on the logit propensity score; (2) propensityThe Journal of Thoracic and Cardiovascular Surgery c Volume 139, Number 6 1513
FIGURE 2. Top, Overall (n ¼ 347, gray line) and late (n ¼ 314, black
line) Kaplan–Meier survival for reoperative coronary artery bypass grafting
(CABG). Error bars represent the standard error (Std. Err.) survival
estimates at selected time points (1, 2, 4, 6, 8, and 10 years). The black
line through the overall Kaplan-Meier data represents the multiphase
model fit. The insert shows early-phase mortality. Bottom, Early, late, and
overall hazard functions based on the multiphase model fit shown in the
top panel. Early hazard values approached late hazard values at
approximately 90 days, which was then used to time segment early and
late survival.
FIGURE 1. Top, Year of initial coronary artery bypass grafting (CABG)
surgery data with the corresponding incidence of internal thoracic artery
(ITA) grafting. Bottom, Interval between the first and reoperative CABG
operations for the entire study population and its radial artery (RA) and
saphenous vein (SV) subcohorts.
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propensity-matched RA versus SV survival comparison.
Data Analysis and Statistical Methods
Continuous data were expressed as means  standard deviations.
When applicable, univariate comparisons were done with c2 or Fisher’s
exact tests for categorical variables and the unpaired t test for continuous
variables. Unadjusted survival comparisons for the baseline, propensity-
stratified (quintiles), and matched cohorts were done with Kaplan–Meier
analysis, with statistical significance based on the log-rank (Mantel–
Cox) or Breslow (generalized Wilcoxon) tests. Late survival Cox regres-
sion analysis was performed on time-segmented data by using 90 days as
a cutoff based on a multiphase model fit (Figure 2) that included an early-
phase (log-linear form) and a late (Weibull)–phase component.13 The
grafting method’s effects on survival after reoperative CABG were inves-
tigated by using comparisons of RA versus SV (or no radial) late survival
with risk adjustment through the logit of the RA-use propensity score.
Lastly, although ITA use was included in the propensity score calculation,
the propensity-adjusted analyses were repeated, with ITA grafting at
reoperation (yes/no) forced into the regression model for further confirma-
tion of results. Statistical analysis was conducted with SPSS version 15.0
software (SPSS, Inc, Chicago, Ill). A P value of less than .05 was used to
indicate significance.1514 The Journal of Thoracic and Cardiovascular SurRESULTS
Follow-up was similar for the RA versus SV cohorts (5.7
 3.4 vs 5.8  4.0 years, P ¼ .86), and 112 (50 in the RA
and 62 in the SV cohorts) deaths were documented. Early
death within 90 days of surgical intervention occurred in
33 (9.5%) patients and was not significantly different for
the RA versus SV cohorts (15/203 [7.4%] vs 18/144
[12.5%], P ¼ .14). The overall unadjusted late survival
for the remaining 314 patients was 95.5%, 81.8%, and
67.7% at 1, 5, and 10 years, respectively. The corresponding
late outcomes were substantially better for the RA versus SV
cohorts, with survival values of 97.3% versus 92.9%
(1 year), 84.9% versus 77.2% (5 years), and 74.1% versus
60.3% (10 years; P ¼ .008, Breslow; Figure 3, top). Thesegery c June 2010
FIGURE 3. Comparison of unadjusted late survival after reoperative cor-
onary artery bypass grafting (CABG) for patients with radial artery grafts
(RA) versus those with saphenous vein grafts (SV) and no radial grafts.
Top, All patients; middle, patients with no internal thoracic artery (ITA)
grafts at reoperation; bottom, patients with ITA grafts at reoperation. P
values were determined by using the Breslow (generalized Wilcoxon) test.
TABLE 3. Unadjusted and risk-adjusted (logit propensity) late (>90
days) mortality hazard ratios using proportional hazard Cox
regression analysis
Patient cohort* RA (n) SV (n)
Hazard ratio
(95% CI) P value
Unadjusted
RA vs SV, all
patients
188 126 0.58 (0.37–0.91) .017
RA vs SV, no ITA 110 67 0.45 (0.27–0.96) .038
RA vs SV, ITA 78 59 0.67 (0.33–1.26) .214
Risk adjusted
RA vs SV 188 126 0.58 (0.35–0.98) .041
Logit (RA propensity
score)
0.99 (0.80–1.25) .991
RA vs SV 188 126 0.58 (0.35–0.98) .041
ITA, forced 1.29 (0.83–2.01) .259
Logit (RA propensity
score)
1.00 (0.80–1.26) .975
RA, Radial artery; SV, saphenous vein; CI, confidence interval; ITA, internal thoracic
artery. *Thirty-three patients experiencing early death (90 days) were excluded from
analysis.
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patients not receiving ITA grafts at the time of reoperation
(no ITA, P ¼ .035; Figure 3, middle) compared with those
who did (ITA, P ¼ .062; Figure 3, bottom).The Journal of Thoracic and CarPropensity-Adjusted Comparison (Late Survival)
The risk-adjusted late survival comparisons through logit
RA-use propensity score–adjusted Cox regression are
summarized in Figure 4 and Table 3. The RA versus SV
late survival risk-adjusted risk ratio was 0.58 (95%
confidence interval, 0.35–0.98; P¼ .04). Notably, this result
is unchanged when ITA use at reoperation was additionally
forced into the regression. Finally, to ascertain that the above
late RA survival benefit was not confounded by whether
a functional (patent) ITA graft was present after reoperation,
we repeated the logit propensity-adjusted analysis limited to
the 269 late (>90 days) survivors (166 in the RA cohort and
103 in the SV cohort) with 1 or more functional ITA grafts
after redo CABG. This analysis resulted in an unchanged
risk-adjusted risk ratio (RA vs SV cohort) of 0.58 (95%
confidence interval, 0.34–0.99; P ¼ .047).
Propensity Quintiles Comparison (Overall Survival)
Results of RA versus SV survival comparisons based on
propensity quintile stratification are provided in Figure E1
and summarized in Table 4. For quintile I (only 18 RA cohort
patients), RA and SV survivals were essentially identical,
whereas a meaningful comparison was not possible for quin-
tile V because group membership included only 4 SV cohort
patients. Alternatively, the RA subcohorts showed superior
survival compared with their SV cohort counterparts for
quintiles II (P ¼ .026), III (P ¼ .086), and IV (P ¼ .13).
Propensity-Matched Comparison (Overall Survival)
Ninety-seven (47.8%) of 203 RA cohort patients were
matched to 97 (67.4%) of 144 SV cohort counterparts based
on the RA-use propensity score with similar matched group
scores (SV vs RA cohort, 0.539  0.180 vs 0.543  0.175;diovascular Surgery c Volume 139, Number 6 1515
FIGURE 4. Comparison of risk-adjusted late coronary artery bypass
grafting (CABG) survival after reoperative CABG for the radial artery
(RA) versus saphenous vein (SV) grafting method subcohorts. Risk adjust-
ment was done with an RA-use propensity score adjustment. The shown
RA and SV survival patterns represent model predictions computed at the
mean of covariates based on the Cox regression analysis results.
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exhibited superior RA survival in both the matched (P ¼
.024) and unmatched (P ¼ .036) cohorts (Figure 5).Predictors of Late Reoperative CABG Survival
Predictors of late mortality after redo CABG derived by
means of multivariate Cox regression analysis included 5
patient factors (Tables 5 and E9]: increased age, lower ejec-
tion fraction, preoperative renal failure (worse), concomitant
noncardiac surgery (worse), and RA grafting (better). These
same variables continued to predict late survival when the
propensity score was forced into the model to account for
residual confounding.DISCUSSION
Reoperation for myocardial revascularization remains
a necessary treatment in some patients with coronaryTABLE 4. Summary of survival comparisons for RA versus SV propensity
No. of patients 5-y Survival (% ± SE
Quintile group RA SV RA SV
I (n ¼ 70) 18 52 62.7  12.4 66.7  6
II (n ¼ 70) 27 43 92.0  5.5 69.5  7
III (n ¼ 70) 41 29 78.2  6.9 64.9  9
IV (n ¼ 70) 54 16 85.9  5.0 73.7 
V (n ¼ 67) 63 4 71.4  5.9 50.5 
Overall (n ¼ 347) 203 144 78.6  3.0 67.5 
RA, Radial artery; SV, saphenous vein; SE, standard error; NA, not available. *Correspondin
on the Breslow test.
1516 The Journal of Thoracic and Cardiovascular Surartery disease because of the recurrence of symptoms of
coronary insufficiency. Vein graft attrition remains the
primary cause for reoperations, and it is estimated that
50% to 60% of vein grafts will be severely compromised
or occluded 10 years after bypass surgery.9,10,14 Current
Society of Thoracic Surgeons statistics indicate that nearly
5% of the CABG procedures done in the United States are
repeat surgical revascularizations. The role of risk factors
has been investigated by many, and as in other
series,9,10,15-17 our redo CABG cohort was characterized
by a relatively high incidence of multiple risk factors
(Table 2) and by the aggressive nature of their early-onset
coronary artery disease given their relatively young age at
the initial CABG operation (55 years [mean]) and at reop-
eration (65 years). Although characteristically a higher-risk
cohort, advancements in reoperative techniques have
favorably affected the surgical results.9,10 In this article
we analyze the less studied potential effects of the grafting
methods on long-term outcomes, specifically focusing on
the choice between RA and SV conduits. Also, this patient
series is distinct from previous reports exploring graft
choice in redo CABG because a substantial majority of
the patients had 1 or more ITA grafts during the first
operation.
Our primary finding is that the choice of RA as opposed
to SV grafting at reoperation did not affect hospital out-
comes but was associated with a substantial risk-adjusted
late survival benefit analogous to what was previously re-
ported when the RA was used as a second arterial con-
duit5,6 or to facilitate total arterial revascularization.7
These results are presumed to be in direct correlation to
the reported better long-term patency of the RA compared
with the SV.4,18-21 Importantly, the additional survival im-
provement was obtained in the presence of the substantial
use of ITA grafts, both during the first CABG operation
(248/347 [71%]) and at reoperation (154/347 [44%]).
The analysis also accounted for the potential confounding
effects caused by between-group differences in 2 important
factors: (1) completeness of revascularization and (2) cu-
mulative arterial versus vein grafting.7 Both of these factors
depend on the total number of functional grafts from both
the first and repeat operations. This was achieved byscore quintile subcohorts*
) 10-y Survival (% ± SE)
RA SV Kaplan–Meiery P value
.6 47.0  16.4 47.6  7.5 .904
.1 81.8  10.8 56.6  8.9 .026
.0 78.2  6.9 59.5  9.7 .086
11.3 78.2  7.1 53.6  15.4 .132
25.0 55.2  9.3 NA .243
3.9 68.6  4.4 52.8  4.8 .002
g Kaplan-Meier survival plots are shown in Figure E1. yKaplan-Meier P value is based
gery c June 2010
FIGURE 5. Kaplan–Meier survival comparison for matched (top, 97
patients each) and unmatched (middle) patients in the radial artery (RA)
versus saphenous vein (SV) cohorts in whom matching was done with the
RA-use propensity score. Bottom, Distribution of propensity scores among
the RA (black bars) and SV (white bars) subcohorts. Error bars represent
the standard error survival estimates at selected time points.
TABLE 5. Predictors of late survival after redo CABG derived by
means of proportional hazard Cox regression analysis
Variables Wald
Risk ratio
(95% CI)
Significance
(P value)
Backward/forward selection
RA graft (vs SV) 4.54 0.59 (0.37–0.96) .033
Ejection fraction (%) 9.35 0.96 (0.94–0.99) .002
Other noncardiac procedure 4.72 2.07 (1.07–3.98) .030
Age (y) 9.80 1.05 (1.02–1.08) .002
Renal failure 18.08 5.83 (2.59–13.1) .000
Forced propensity score
RA graft (vs SV) 5.43 0.53 (0.31–0.90) .020
Ejection fraction (%) 9.16 0.96 (0.94–0.99) .002
Other noncardiac procedure 5.16 2.15 (1.11–4.17) .023
Age (y) 10.51 1.05 (1.02–1.08) .001
Renal failure 18.92 6.27 (2.74–14.4) .000
RA-use propensity
score (logit)
0.90 1.13 (0.88–1.45) .343
Considered variables in addition to ‘‘RA graft (vs SV)’’ and ‘‘RA-use propensity score
(logit)’’ included 3 continuous covariates (‘‘Age [y],’’ ‘‘Body mass index [kg/m2],’’
and ‘‘Ejection fraction [%]’’) and 20 categorical covariates: diabetes, insulin
dependence, renal failure, high cholesterol, hypertension, peripheral vascular disease,
cerebrovascular disease, chronic lung disease, history of myocardial infarction, con-
gestive heart failure, arrhythmia, New York Heart Association class III/IV, left main
disease, coronary vessel disease (1.2 or 3), emergency, off-pump coronary artery
bypass grafting, other cardiac procedure, other noncardiac procedure, patent left inter-
nal thoracic artery (previous coronary artery bypass grafting), and number of arterial
grafts (total). CABG, Coronary artery bypass grafting; CI, confidence interval; RA,
radial artery; SV, saphenous vein.
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Zacharias et al Acquired Cardiovascular Diseasecombining the patent grafts from the first operation (Table
1) with the new grafts and incorporating the cumulative
grafting data along with the associated vessel disease inThe Journal of Thoracic and Carthe propensity score model used for risk-adjusted survival
calculations.
A voluminous number of reports have investigated early
outcomes of reoperative CABG, including the effects of
grafting approaches.22-26 Studies investigating the late
effects of arterial and vein conduits in reoperative CABG
are limited, and most of these report a late benefit of arterial
(ITA or RA) over SV grafts. Loop and colleagues22 and Kaul
and associates23 reported late outcomes from large observa-
tional redo CABG series, showing a 10% survival benefit at
10 years using a single ITA as opposed to an SV at
reoperation. However, concerns have been raised regarding
incomplete risk adjustment for the notable differences in
demographics and risk factors between the 2 groups.27
Weintraub and coworkers24 did not find a similar survival
benefit with the use of ITAs at reoperation. Dougenis and
Brown25 analyzed the long-term results of 103 patients
undergoing reoperative CABG (all with SVs only grafting
at initial CABG) and divided them into those receiving (1)
1 or more ITA grafts (n ¼ 53) or (2) only SV grafts (n ¼
50) at reoperation. Their results in these reasonably matched
groups showed a nonsignificant trend for better 5-year
survival in patients receiving ITAs (91.6%) compared
with those receiving SVs (85.3%). Despite the small
number of patients in their analysis, these authors were
able to demonstrate a substantially better event-free survival
when ITAs were used at the time of reoperation.diovascular Surgery c Volume 139, Number 6 1517
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both for both the RA and SV cohorts could have influenced
our finding of a superior RA survival. We addressed this
concern in our risk-adjusted analysis by appropriately
accounting for the combined number and type of grafts in
our propensity model and consequently in the risk-adjusted
survival comparisons (Figure 3). Additionally, the superior
survival of the RA cohort persisted when this population
was divided into patients who did or did not receive ITA
grafts at reoperation (Figure 2). In a related analysis,
Tatoulis and colleagues26 compared the results of redo
CABG with RA grafting with those of a historical control
group undergoing redo CABG with SV grafts, with both
groups including patients with or without additional ITA
grafts at reoperation. They concluded that the RA use was
associated with excellent early results that are equal or supe-
rior to those seen with SV grafting. Although they found no
significant difference in 3-year unadjusted survival, theywere
able to achieve total arterial revascularization in 92% of
the RA cohort,26 with potential long-term survival benefits.7
Limitations of the study include its retrospective and
observational nature. Ideally, the question of whether RA
versus SV grafting for redo CABG will improve long-term
outcomes is best addressed in prospective randomized trials.
Second, the possibility of residual confounding factors is
possible. However, we believe that the comprehensiveness
of the propensity model used in the risk adjustment,
including initial CABG grafting and patency data, and the
multivariate modeling mitigates this concern.
Third, the cause of death in our patient population is
unknown, and consequently the death rate might be
independent of cardiac factors. Yet the likelihood that
noncardiac deaths explain this risk-adjusted difference in
late survival is low.
Lastly, our analysis would have been enhanced
substantially if long-term graft patency comparisons were
similarly available after the reoperation.
Weconclude that the use ofRAasopposed toSVgrafting in
the redopopulation,with orwithout concomitant ITAgrafts, is
associated with a substantial improvement in late survival.
This benefit is likely derived from the increased overall num-
ber of arterial grafts used for revascularization, which is an
important objective for successful surgical treatment.
References
1. Loop F, Lytle B, Cosgrove D, et al. Influence of the internal-mammary-artery
graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314:1-6.
2. Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with inter-
nal-thoracic-artery grafts—effects on survival over a 15-year period. N Engl J
Med. 1996;334:216-9.
3. Lytle BW, Blackstone EH, Sabik JF, Houghtaling P, Loop FD, Cosgrove DM.
The effect of bilateral internal thoracic artery grafting on survival during 20
postoperative years. Ann Thorac Surg. 2004;78:2005-12.1518 The Journal of Thoracic and Cardiovascular Sur4. Rankin JS, Tuttle RH, Wechsler AS, Teichmann TL, Glower DD, Califf RM.
Techniques and benefits of multiple internal mammary artery bypass at 20 years
of follow-up. Ann Thorac Surg. 2007;83:1008-14.
5. Zacharias A, Habib RH, Schwann TA, Riordan CJ, Durham SJ, Shah A.
Improved survival with radial artery versus vein conduits in coronary bypass
surgery with left internal thoracic artery to left anterior descending artery grafting.
Circulation. 2004;109:1489-96.
6. Schwann TA, Zacharias A, Riordan CJ, Durham SJ, Shah AS, Habib RH.
Survival and graft patency following coronary artery bypass grafting with
coronary endarterectomy: role of arterial versus vein conduits. Ann Thorac
Surg. 2007;84:25-31.
7. Zacharias A, Schwann TA, Riordan CJ, Durham SJ, Shah A, Habib RH. Late
results of conventional versus all-arterial revascularization based on internal
thoracic and radial artery grafting. Ann Thorac Surg. 2009;87:19-26, e2.
8. Schwann TA, Zacharias A, Riordan CJ, Durham SJ, Shah AS, Habib RH.
Sequential radial artery grafts for multi-vessel CABG: 10-year survival and
angiography results. Ann Thorac Surg. 2009;88:31-9.
9. Lytle BW, McElroy D, McCarthy P, et al. Influence of arterial coronary bypass
grafts on the mortality in coronary reoperations. J Thorac Cardiovasc Surg.
1994;107:675-83.
10. Sabik JF III, Blackstone EH, Houghtaling PL, et al. Is reoperation still a risk factor
in coronary artery bypass surgery? Ann Thorac Surg. 2005;80:1719-27.
11. Blackstone EH. Comparing apples to oranges. J Thorac Cardiovasc Surg. 2002;
123:8-15.
12. Harrell FE Jr. Regression modeling strategies: with application to linear models,
logistic regression, and survival analysis. New York: Springer-Verlag; 2001.
13. Myers WO, Blackstone EH, Davis K, Foster ED, Kaiser GC. CASS Registry
long-term surgical survival. Coronary Artery Surgery Study. J Am Coll Cardiol.
1999;33:488-98.
14. Domanski MJ, Borkowf CB, Campeau L, et al. Prognostic factors for
atherosclerosis progression in saphenous vein grafts. J Am Coll Cardiol. 2000;
36:1877-83.
15. Christenson JT, Schmuziger M, Simonet F. Reoperative coronary artery bypass
procedures: risk factors for early mortality and late survival. Eur J Cardiothorac
Surg. 1997;11:129-33.
16. Alexander JH, Hafley G, Harrington RA, et al. Efficacy and safety of edifoligide,
an E2F transcription factor decoy, for prevention of vein graft failure following
coronary artery bypass graft surgery: PREVENT IV: a randomized controlled
trial. JAMA. 2005;294:2446-54.
17. Mishra YK, Collison SP, Malhotra R, et al. Ten-year experience with single-
vessel and multivessel reoperative off-pump coronary artery bypass grafting.
J Thorac Cardiovasc Surg. 2008;135:527-32.
18. Possati G, Gaudino M, Alessandrini F, et al. Midterm clinical and angiographic
results of radial artery grafts used for myocardial revascularization. J Thorac
Cardiovasc Surg. 1998;116:1015-21.
19. Desai ND, Cohen EA, Naylor D, Fremes SE. A randomized comparison of radial-
artery and saphenous-vein coronary bypass grafts.NEngl J Med. 2004;351:2302-9.
20. Buxton BF, Raman JS, Ruengsakulrach P, et al. Radial artery patency and clinical
outcomes: five-year interim results of a randomized trial. J Thorac Cardiovasc
Surg. 2003;125:1363-71.
21. Collins P, Webb CM, Chong CF, Moat NE, for the Radial Artery Versus Saphe-
nous Vein Patency (RSVP) Trial Investigators. Radial artery versus saphenous
vein patency randomized trial: five-year angiographic follow-up. Circulation.
2008;117:2859-64.
22. Loop FD, Lytle BW, Cosgrove DM, et al. Reoperation for coronary atherosclero-
sis. Changing practice in 2509 consecutive patients. Ann Surg. 1990;212:378-85.
23. Kaul TK, Fields BL,Wyatt DA, Jones CR, Kahn DR. Reoperative coronary artery
bypass surgery: early and late results and management in 1300 patients.
J Cardiovasc Surg. 1995;36:303-12.
24. Weintraub WS, Jones EL, Craver JM, et al. In-hospital and long-term outcome
after reoperative coronary artery bypass graft surgery. Circulation. 1995;92(suppl
II):II50.
25. Dougenis D, Brown AH. Long term results of reoperations for recurrent angina
with internal mammary artery versus saphenous vein grafts. Heart. 1998;80:9-13.
26. Tatoulis J, Buxton BF, Fuller JA. The radial artery in reoperative coronary bypass
surgery: a 5-year experience. J Card Surg. 2004;19:296-302.
27. Taggart DP. Arterial or venous conduits for redo coronary artery bypass grafting?
Heart. 1998;80:1-2.gery c June 2010
FIGURE E1. Kaplan–Meier comparisons for propensity score quintile groups. A summary of results at 5 and 10 years is also provided in Table 4 of the
article. SV, Saphenous vein; RA, radial artery; CABG, coronary artery bypass grafting.
TABLE E1. Annual volumes of reoperations over the study period
No. of CABG reoperations
Surgical
year All RA cohort
SV
cohort
Isolated
CABG
CABG
plus
1996 34 12 (35%) 22 (65%) 30 4
1997 37 15 (41%) 22 (59%) 34 3
1998 35 20 (57%) 15 (43%) 32 3
1999 27 12 (44%) 15 (56%) 22 5
2000 31 15 (48%) 16 (52%) 28 3
2001 48 32 (67%) 16 (33%) 33 15
2002 37 23 (62%) 14 (38%) 27 10
2003 41 34 (83%) 7 (17%) 32 9
2004 25 18 (72%) 7 (28%) 22 3
2005 13 7 (54%) 6 (46%) 11 2
2006 10 9 (90%) 1 (10%) 6 4
2007 9 6 (67%) 3 (33%) 6 3
1996–2007 347 203 (59%) 144 (41%) 283 (82%) 64 (18%)
Annual Redo CABG volumes: median ¼ 32 (range, 9–48); 29  13 cases per year.
This excludes coronary artery bypass grafting reoperations combined with other major
cardiovascular operations, such as valve and aortic surgery. CABG, Coronary artery
bypass grafting; CABG plus, coronary artery bypass grafting concomitant with other
procedures (eg, carotid endarterectomy, lung operation, or the maze procedure).
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TABLE E2. Grafting data summary from prior or ‘‘initial’’ CABG operation for the reoperative CABG cohort (n ¼ 347)
Conduit/
target LAD D1 D2 Ramus CX OM1 OM2 OM3 RCA PDA LVB AM
All types 291 135 6 18 57 128 47 7 143 86 11 3
ITA (any) 218 25 1 1 2 3 1 0 11 1 1 1
LITA 215 20 1 1 2 2 1 0 0 0 0 0
RITA 2 1 0 0 0 1 0 0 11 1 0 1
Free ITA 1 1 0 0 0 0 0 0 0 0 1 0
RA 1 4 0 0 1 8 3 0 4 12 1 0
SV 74 109 5 17 54 117 43 7 128 73 9 2
CABG, Coronary artery bypass grafting; LAD, left anterior descending artery;D1 andD2, first and second diagonal arteries;Ramus, ramus intermedius;CX, circumflex artery;OM1,
OM2, and OM3, first, second, and third obtuse marginal artery; RCA, right coronary artery; PDA, posterior descending artery; LVB, left ventricular branch; AM, acute marginal
artery; ITA, internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; SV, saphenous vein.
TABLE E3. Summary of graft failure (>75% stenosis) data from ‘‘initial’’ CABG for the entire reoperative CABG cohort (n ¼ 347)
Conduit/
target LAD D1 D2 Ramus CX OM1 OM2 OM3 RCA PDA LVB AM
All types 96 89 3 12 44 88 35 7 104 64 7 1
ITA (any) 45 6 0 1 1 2 0 0 7 0 0 0
LITA 44 5 0 1 1 1 0 0 0 0 0 0
RITA 0 1 0 0 0 1 0 0 8 0 0 0
Free ITA 1 0 0 0 0 0 0 0 0 0 0 0
RA 0 2 0 0 0 7 1 0 3 9 0 0
SV 50 81 3 11 43 79 34 7 93 55 7 1
CABG, Coronary artery bypass grafting; LAD, left anterior descending artery;D1 andD2, first and second diagonal arteries;Ramus, ramus intermedius;CX, circumflex artery;OM1,
OM2, and OM3, first, second, and third obtuse marginal artery; RCA, right coronary artery; PDA, posterior descending artery; LVB, left ventricular branch; AM, acute marginal
artery; ITA, internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; SV, saphenous vein.
TABLE E4. Grafting data summary from prior or ‘‘initial’’ CABG operation for the reoperative CABG subcohort with saphenous vein and no
radial artery grafts (n ¼ 147)
Conduit/
target LAD D1 D2 Ramus CX OM1 OM2 OM3 RCA PDA LVB AM
All types 118 49 3 8 30 46 14 2 67 31 5 1
ITA (any) 81 9 0 1 2 0 0 0 6 0 1 0
LITA 80 9 0 1 2 0 0 0 0 0 0 0
RITA 1 0 0 0 0 0 0 0 6 0 0 0
Free ITA 0 0 0 0 0 0 0 0 0 0 1 0
RA 0 3 0 0 1 6 1 0 2 7 1 0
SV 37 37 3 7 27 40 13 2 59 24 3 1
CABG, Coronary artery bypass grafting; LAD, left anterior descending artery;D1 andD2, first and second diagonal arteries;Ramus, ramus intermedius;CX, circumflex artery;OM1,
OM2, and OM3, first, second, and third obtuse marginal artery; RCA, right coronary artery; PDA, posterior descending artery; LVB, left ventricular branch; AM, acute marginal
artery; ITA, internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; SV, saphenous vein.
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TABLE E5. Summary of graft failure (>75% stenosis) data from ‘‘initial’’ CABG for the reoperative CABG subcohort with saphenous vein and no
radial artery grafts (n ¼ 147)
Conduit/
target LAD D1 D2 Ramus CX OM1 OM2 OM3 RCA PDA LVB AM
All types 45 35 3 6 22 36 13 2 49 26 2 1
ITA (any) 16 3 0 1 1 0 0 0 5 0 0 0
LITA 16 3 0 1 1 0 0 0 0 0 0 0
RITA 0 0 0 0 0 0 0 0 5 0 0 0
Free ITA 0 0 0 0 0 0 0 0 0 0 0 0
RA 0 2 0 0 0 6 1 0 2 6 0 0
SV 28 30 3 5 21 30 12 2 42 20 2 1
CABG, Coronary artery bypass grafting; LAD, left anterior descending artery;D1 andD2, first and second diagonal arteries;Ramus, ramus intermedius;CX, circumflex artery;OM1,
OM2, and OM3, first, second, and third obtuse marginal artery; RCA, right coronary artery; PDA, posterior descending artery; LVB, left ventricular branch; AM, acute marginal
artery; ITA, internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; SV, saphenous vein.
TABLE E6. Grafting data summary from prior or ‘‘initial’’ CABG operation for the reoperative CABG subcohort with radial artery grafts
(n ¼ 200)
Conduit/
target LAD D1 D2 Ramus CX OM1 OM2 OM3 RCA PDA LVB AM
All types 175 86 3 10 27 82 33 5 76 55 6 2
ITA (any) 137 13 1 0 0 3 1 0 5 1 0 1
LITA 135 11 1 0 0 2 1 0 0 0 0 0
RITA 1 1 0 0 0 1 0 0 5 1 0 1
Free ITA 1 1 0 0 0 0 0 0 0 0 0 0
RA 1 1 0 0 0 2 2 0 2 5 0 0
SV 37 72 2 10 27 77 30 5 69 49 6 1
CABG, Coronary artery bypass grafting; LAD, left anterior descending artery;D1 andD2, first and second diagonal arteries;Ramus, ramus intermedius;CX, circumflex artery;OM1,
OM2, and OM3, first, second, and third obtuse marginal artery; RCA, right coronary artery; PDA, posterior descending artery; LVB, left ventricular branch; AM, acute marginal
artery; ITA, internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; SV, saphenous vein.
TABLE E7. Summary of graft failure (>75% stenosis) data from ‘‘initial’’ CABG for the reoperative CABG subcohort with radial artery grafts
(n ¼ 200)
Conduit/
target LAD D1 D2 Ramus CX OM1 OM2 OM3 RCA PDA LVB AM
All types 51 54 0 6 22 52 22 5 55 38 5 0
ITA (any) 30 3 0 0 0 2 0 0 3 0 0 0
LITA 29 2 0 0 0 1 0 0 0 0 0 0
RITA 0 1 0 0 0 1 0 0 2 0 0 0
Free ITA 1 0 0 0 0 0 0 0 0 0 0 0
RA 0 0 0 0 0 1 0 0 1 3 0 0
SV 23 51 0 6 22 49 22 5 51 35 5 0
CABG, Coronary artery bypass grafting; LAD, left anterior descending artery;D1 andD2, first and second diagonal arteries;Ramus, ramus intermedius;CX, circumflex artery;OM1,
OM2, and OM3, first, second, and third obtuse marginal artery; RCA, right coronary artery; PDA, posterior descending artery; LVB, left ventricular branch; AM, acute marginal
artery; ITA, internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; SV, saphenous vein.
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TABLE E8. Grafting data summary from the redo operation for the entire study CABG reoperation cohort (n ¼ 347)
Conduit/
target LAD D1 D2 Ramus CX OM1 OM2 OM3 RCA PDA LVB AM All targets
All types 206 125 2 41 28 163 83 22 77 168 29 6 950
ITA (any) 114 16 1 4 1 6 1 0 10 6 1 1 161
LITA 66 5 1 1 1 1 0 0 0 0 0 0 75
RITA 40 6 0 1 0 3 0 0 9 5 0 1 65
Free ITA 8 5 0 2 0 2 1 0 1 1 1 0 21
RA 41 35 0 18 11 68 22 6 14 37 8 0 260
SV 51 74 1 19 16 89 60 16 53 125 20 5 529
CABG, Coronary artery bypass grafting; LAD, left anterior descending artery;D1 andD2, first and second diagonal arteries;Ramus, ramus intermedius;CX, circumflex artery;OM1,
OM2, and OM3, first, second, and third obtuse marginal artery; RCA, right coronary artery; PDA, posterior descending artery; LVB, left ventricular branch; AM, acute marginal
artery; ITA, internal thoracic artery; LITA, left internal thoracic artery; RITA, right internal thoracic artery; RA, radial artery; SV, saphenous vein.
TABLE E9. Results of proportional hazard Cox regression based on 23 forced patient covariates in addition to RA graft use and RA-use propensity
score
Variables B SE Wald Significance (P value) Risk ratio 95% CI for Exp(B)
RA graft (vs SV) 1.05 0.41 6.52 .011 0.35 0.16 0.78
RA-use propensity
score (logit)
0.14 0.21 0.42 .515 1.15 0.76 1.72
Covariates (continuous)
Age (y) 0.05 0.02 10.58 .001 1.05 1.02 1.08
Body mass
index (kg/m2)
0.02 0.03 0.42 .516 1.02 0.96 1.08
Ejection fraction (%) 0.04 0.02 5.72 .017 0.96 0.94 0.99
Covariates (categorical)
Diabetes 0.31 0.31 1.01 .315 1.36 0.74 2.50
Insulin dependence 0.17 0.42 0.15 .696 1.18 0.51 2.71
Renal failure 1.97 0.57 11.92 .001 7.20 2.35 22.10
High cholesterol 0.24 0.35 0.46 .499 1.27 0.64 2.51
Hypertension 0.02 0.41 0.00 .960 0.98 0.44 2.17
Peripheral vascular
disease
0.10 0.35 0.08 .774 1.11 0.56 2.19
Cerebrovascular disease 0.10 0.31 0.10 .751 0.91 0.49 1.67
Chronic lung disease 0.04 0.32 0.01 .909 0.96 0.51 1.82
History of myocardial
infarction
0.09 0.28 0.11 .744 0.91 0.53 1.58
Congestive heart failure 0.06 0.42 0.02 .887 1.06 0.46 2.43
Arrhythmia 0.09 0.35 0.06 .802 0.92 0.46 1.82
NYHA class III/IV 0.67 0.37 3.23 .072 1.96 0.94 4.08
Left main disease 0.48 0.30 2.62 .105 1.62 0.90 2.90
Vessel disease
(reference¼1-vessel
disease)
0.55 .759
2-Vessel disease 0.02 0.71 0.00 .975 0.98 0.24 3.95
3-Vessel disease 0.29 0.64 0.20 .656 0.75 0.21 2.65
Emergency 0.17 0.78 0.05 .826 1.19 0.26 5.52
Off-pump CABG 0.19 0.54 0.12 .732 0.83 0.29 2.41
Other cardiac procedure 0.16 0.52 0.09 .767 0.86 0.31 2.39
Other noncardiac
procedure
0.85 0.41 4.34 .037 2.34 1.05 5.21
Patent LITA (previous
CABG)
0.15 0.30 0.24 .625 0.86 0.48 1.55
No. of arterial
grafts (total)
0.26 0.19 1.97 .161 1.30 0.90 1.89
RA, Radial artery; CI, confidence interval; SV, saphenous vein; NYHA, New York Heart Association; CABG, coronary artery bypass grafting; LITA, left internal thoracic artery.
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